Literature DB >> 24698526

Clinico-pathological factors influencing surgical outcome in drug resistant epilepsy secondary to mesial temporal sclerosis.

B V Savitr Sastri1, A Arivazhagan1, Sanjib Sinha2, Anita Mahadevan3, R D Bharath4, J Saini4, R Jamuna5, J Keshav Kumar5, S L Rao5, B A Chandramouli1, S K Shankar3, P Satishchandra6.   

Abstract

BACKGROUND: Mesial temporal sclerosis (MTS) is the most common cause of drug resistant epilepsy amenable for surgical treatment and seizure control.
METHODS: This study analyzed the outcome of patients with MTS following anterior temporal lobectomy and amygdalohippocampectomy (ATL-AH) over 10 years and correlated the electrophysiological and radiological factors with the post operative seizure outcome.
RESULTS: Eighty seven patients were included in the study. Sixty seven (77.2%) patients had an Engel Class 1 outcome, 9 (11.4%) had Class 2 outcome. Engel's class 1 outcome was achieved in 89.9% at 1 year, while it reduced slightly to 81.9% at 2 years and 76.2% at 5 year follow up. Seventy seven (88.5%) patients had evidence of hippocampal sclerosis on histopathology. Dual pathology was observed in 19 of 77 specimens with hippocampal sclerosis, but did not influence the outcome. Factors associated with an unfavorable outcome included male gender (p=0.04), and a higher frequency of pre-operative seizures (p=0.005), whereas the presence of febrile seizures (p=0.048) and loss of hippocampal neurons in CA4 region on histopathology (p=0.040) were associated with favorable outcome. The effect of CA4 loss on outcome is probably influenced by neuronal loss in other subfields as well since isolated CA4 loss was rare. Abnormal post operative EEG at the end of 1 week was found to be a significant factor predicting unfavorable outcome (p=0.005). On multivariate analysis, the pre-operative seizure frequency was the only significant factor affecting outcome.
CONCLUSIONS: The present study observed excellent seizure free outcome in a carefully selected cohort of patients with MTS with refractory epilepsy. The presence of dual pathology did not influence the outcome.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dual pathology; Epilepsy surgery; Hippocampal sclerosis; Outcome; Pathology; Temporal lobe epilepsy

Mesh:

Substances:

Year:  2014        PMID: 24698526     DOI: 10.1016/j.jns.2014.03.026

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  In vivo MRI signatures of hippocampal subfield pathology in intractable epilepsy.

Authors:  Maged Goubran; Boris C Bernhardt; Diego Cantor-Rivera; Jonathan C Lau; Charlotte Blinston; Robert R Hammond; Sandrine de Ribaupierre; Jorge G Burneo; Seyed M Mirsattari; David A Steven; Andrew G Parrent; Andrea Bernasconi; Neda Bernasconi; Terry M Peters; Ali R Khan
Journal:  Hum Brain Mapp       Date:  2015-12-17       Impact factor: 5.038

2.  Enhanced excitability of the hippocampal CA2 region and its contribution to seizure activity in a mouse model of temporal lobe epilepsy.

Authors:  Alexander C Whitebirch; John J LaFrancois; Swati Jain; Paige Leary; Bina Santoro; Steven A Siegelbaum; Helen E Scharfman
Journal:  Neuron       Date:  2022-08-19       Impact factor: 18.688

3.  The number of seizures needed in the EMU.

Authors:  Aaron F Struck; Andrew J Cole; Sydney S Cash; M Brandon Westover
Journal:  Epilepsia       Date:  2015-07-27       Impact factor: 5.864

4.  Variability in clinical assessment of neuroimaging in temporal lobe epilepsy.

Authors:  Aaron F Struck; Michael B Westover
Journal:  Seizure       Date:  2015-07-02       Impact factor: 3.184

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.